Interleukin 17D (IL17D) (N-Term) Peptide
IL17D
Reactivity: Human
Host: Synthetic
BP, WB
Catalog No. ABIN978479
Quick Overview for Interleukin 17D (IL17D) (N-Term) Peptide (ABIN978479)
Target
IL17D
(Interleukin 17D (IL17D))
Origin
Human
Source
Synthetic
Application
Blocking Peptide (BP), Western Blotting (WB)
-
-
Protein Region
- N-Term
-
Sequence
- MLVAGFLLAL PPSWAAGAPR AGRRPARPRG CADRPEELLE QLYGRLAAGV
-
Characteristics
- This is a synthetic peptide designed for use in combination with anti-IL17D Antibody(ARP57724_P050),. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
Purification
- Purified
-
-
-
-
Application Notes
- Each Investigator should determine their own optimal working dilution for specific applications.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Concentration
- 1 mg/mL
-
Buffer
- Final peptide concentration is 1 mg/mL in PBS.
-
Handling Advice
- Avoid repeated freeze-thaw cycles.
-
Storage
- -20 °C
-
Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
-
- IL17D (Interleukin 17D (IL17D))
-
Background
-
The protein encoded by this gene is a cytokine that shares the sequence similarity with IL17. The treatment of endothelial cells with this cytokine has been shown to stimulate the production of other cytokines including IL6, IL8 and CSF2/ GM-CSF. The increased expression of IL8 induced by this cytokine was found to be NF-kappa B-dependent.
Alias Symbols: FLJ30846, IL-17D, IL-22, IL-27, IL27
Protein Size: 202 -
Molecular Weight
- 21 kDa
-
Gene ID
- 53342
-
NCBI Accession
- NM_138284, NP_612141
-
UniProt
- Q8TAD2
Target
-
You are here:
